Search Results - "BELEGAJE, R"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors by SCHOEPP, D. D, JOHNSON, B. G, MONN, J. A, WRIGHT, R. A, SALHOFF, C. R, MAYNE, N. G, WU, S, COCKERHAM, S. L, BURNETT, J. P, BELEGAJE, R, BLEAKMAN, D

    Published in Neuropharmacology (1997)
    “…The novel compound LY354740 is a conformationally constrained analog of glutamate, which was designed for interaction at metabotropic glutamate (mGlu)…”
    Get full text
    Journal Article
  2. 2

    Benefit of endovascular thrombectomy for M2 middle cerebral artery occlusion in the ARISE II study by de Havenon, Adam, Narata, Ana Paula, Amelot, Aymeric, Saver, Jeffrey L, Bozorgchami, Hormozd, Mattle, Heinrich Paul, Ribo, Marc, Andersson, Tommy, Zaidat, Osama O

    Published in Journal of neurointerventional surgery (01-09-2021)
    “…The benefit of endovascular thrombectomy for acute ischemic stroke with M2 segment middle cerebral artery occlusion remains controversial, with uncertainty and…”
    Get more information
    Journal Article